Dihexa record · updated 17h ago
Experimental nootropic peptide investigated for neuroprotection, memory, and stroke/spinal-cord recovery.
How it works: PI3K/AKT signaling pathway activation
Development stage
where Dihexa sits between preclinical work and regulatory approval- 1ClearedPreclinicalAnimal / in-vitro work
- 2ClearedPhase 1Safety in humans
- 3ClearedPhase 2Efficacy signal
- 4ClearedPhase 3Confirmatory trials
- 5CurrentApprovedCleared by a regulator
Stage is inferred from the highest trial phase in the indexed corpus and 7 registered trials. It describes the research record, not a recommendation.
Mass and formula from PubChem CID 129010512. No verified residue count for this compound.
What people are saying
anecdotal · not evidenceUnverified first-hand accounts from public forums. These are not studies: nobody checked what was taken, whether it was what the label said, or what else was going on. They count for nothing in the evidence grade above and are shown because a reader searching Dihexa will meet them anyway, and meeting them next to a graded evidence base is better than meeting them alone.